Brain Tunnelgenix Technologies, Corp.

BTT™ Corp. is a MedTech company providing services and solutions to patients with infectious and neurodegenerative diseases by combining the power of Brain Thermodynamics, the Internet of Things, and Predictive Models using Artificial Intelligence. BTT™ Corp. develops, manufactures, and markets solutions based on the brain thermal tunnel with a broad range of applications. The company is the sole licensee of proprietary products that track brain temperature in a noninvasive and continuous way using the brain temperature tunnel. The brain thermal tunnel was discovered by BTT™ Chief Scientific and Medical Officer, Dr. Marc Abreu, of Harvard Medical School and Yale School of Medicine. An innovative physicist and medical doctor board-certified in Anesthesiology and Ophthalmology. While at Yale, he discovered the brain thermal tunnel, which for the first time in history enabled noninvasive, continuous measurement of human brain temperature.  Dr. Abreu is one of the world's foremost experts on body thermal energy, having studied brain thermodynamics for two decades and inventing technologies that resulted in dozens of patents. He developed the BTT™ Abreu  700 system, an FDA-cleared, computer-based device with a microsensor that measures brain temperature. The BTT™ Abreu  700  provides the most accurate and true brain temperature without corrective factors found in all other digital and infrared thermometers. Brain Tunnelgenix Technologies, Corp.™, a MedTech company, utilizes advanced sensors, software, and artificial intelligence to uniquely capture brain thermodynamic signatures. Brain Tunnelgenix Technologies Corp™ has developed the world's first non-invasive and continuous wearable technology that tracks human brain temperature through the Brain Thermal Tunnel, the BTT™ .

• Employees 7
• Founded 2016
• Annual Revenue $3000000
• Total Funding $45762174